RBF Capital, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 51 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
RBF Capital, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$183,000
-19.7%
166,0780.0%0.01%
-60.0%
Q2 2020$228,000
+20.6%
166,0780.0%0.02%0.0%
Q1 2020$189,000
-20.6%
166,078
+59.2%
0.02%
+8.7%
Q4 2019$238,000–104,353–0.02%–
 Download
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q2 2020.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders